February 24 | 2022

2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021

Read more
January 21 | 2022

New Institutional shareholder

Read more
January 11 | 2022

IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica

Read more
January 5 | 2022

IndiTreat® to be distributed in Poland by Perlan Technologies

Read more
December 22 | 2021

First IndiTreat® order received from Labormed, Slovenia

Read more
December 16 | 2021

First hospital joins the IndiTreat® Evaluation Program IGNITE

Read more
December 14 | 2021

2cureX launches IndiTreat® mCRC Start test to guide 1st line treatment

Read more
December 13 | 2021

2cureX reaches the goals for the 2021 rollout plan

Read more
December 9 | 2021

2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey

Read more
November 25 | 2021

2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021

Read more
November 25 | 2021

2cureX publishes interim report for the third quarter and first nine months of 2021

Read more
October 29 | 2021

2cureX – Banbrytande cancerbehandlingstest rullas ut – Mangold Insight Analys

Read more
October 15 | 2021

2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant.

Read more
October 12 | 2021

2cureX provides commercial goals for 2022 at Live Strategy Update on the 12th of October 2021.

Read more
October 5 | 2021

2cureX signs distribution agreement with Labormed in Slovenia

Read more
September 28 | 2021

Specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain

Read more
August 26 | 2021

2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021

Read more
August 26 | 2021

2cureX publishes interim report for the second quarter and first half of 2021

Read more